Schedule 13G ownership disclosure
Allena Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 018119107
Event date: 2019-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 790,100
- Percent of class
- 3.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001105806-20-000009
- Form type
- SC 13G
- Filer
- Allena Pharmaceuticals, Inc.
- CIK
- CIK 1624658
- Filed
- Feb 14, 2020
- Reporting period
- Dec 31, 2019
- Description
- Schedule 13G beneficial ownership